The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
Efficacy and safety of ramucirumab containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma.
 
Saori Mishima
No Relationships to Disclose
 
Akihito Kawazoe
No Relationships to Disclose
 
Hiroshi Matsumoto
No Relationships to Disclose
 
Yasutoshi Kuboki
Honoraria - Bayer; Taiho Pharmaceutical
 
Hideaki Bando
Research Funding - AstraZeneca; Sysmex
 
Takashi Kojima
Honoraria - Amgen
Research Funding - Merck Serono (Inst)
Patents, Royalties, Other Intellectual Property - Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst)
 
Toshihiko Doi
Consulting or Advisory Role - Amgen; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; MSD; Novartis
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Atsushi Ohtsu
Employment - Celgene (I)
Research Funding - Bristol-Myers Squibb
 
Takayuki Yoshino
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline K.K. (Inst)
 
Elizabeth M Nonte
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Sudhakar Chintharlapalli
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Patents, Royalties, Other Intellectual Property - Lilly
 
Aejaz Nasir
No Relationships to Disclose
 
Takeshi Kuwata
No Relationships to Disclose
 
Kohei Shitara
Honoraria - Abbvie; Novartis; Ono Pharmaceutical; Yakult Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Lilly; Pfizer; Takeda
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); MSD (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)